Almirall seeks new compounds to treat atopic dermatitis, psoriasis, actinic keratosis, acne, and related dermatological diseases.
Scientists from all over the world have been registered on AlmirallShare and submit their solutions to improve skin health.
Deadline of December, 31th, 2017. Preclinical Models call is offering financial and scientific support to develop novel pharmacologically validated in vitro and in vivo research translational preclinical models in skin diseases.
Almirall launches AlmirallShare, an Open Innovation platform, aimed to bring together creative minds and team up with experts around the world to find innovative solutions for skin health.